Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Michael

Showing results (1141-1150 of 1,306) with videos related to

Pageof 131
Sort By:
Heart Rhythm|February 2, 2012
Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndromeJason Costa, Coeli M Lopes, Alon Barsheshet, et al.
JACC. Cardiovascular Interventions|July 24, 2024
3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid StudyFiras Zahr, Basel Ramlawi, Michael J Reardon, et al.
Journal of the American College of Cardiology|November 24, 2018
Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart FailureDaniel B Mark, Patricia A Cowper, Kevin J Anstrom, et al.
The New England Journal of Medicine|January 7, 2011
AIP mutation in pituitary adenomas in the 18th century and todayHarvinder S Chahal, Karen Stals, Martina Unterländer, et al.
Journal of the American College of Cardiology|August 31, 2019
Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection FractionJames L Januzzi, Tariq Ahmad, Hillary Mulder, et al.
JACC. Heart Failure|December 3, 2014
Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trialW H Wilson Tang, Matthias Dupont, Adrian F Hernandez, et al.
Canadian Family Physician Medecin De Famille Canadien|October 13, 2023
Lipid-lowering therapies for cardiovascular disease prevention and management in primary care: PEER umbrella systematic review of systematic reviewsNicolas Dugré, Adrienne J Lindblad, Danielle Perry, et al.
Circulation|June 29, 2026
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)Mary Norine Walsh, Lars Kober, Karen Sliwa, et al.
JACC. Heart Failure|April 13, 2020
Endpoints in Heart Failure Drug Development: History and FutureMona Fiuzat, Naomi Lowy, Norman Stockbridge, et al.
European Heart Journal|March 24, 2022
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trialScott D Solomon, Brian L Claggett, Zi Michael Miao, et al.
Pageof 131

Showing results (1141-1150 of 1,306) with videos related to

Sort By:
Pageof 131
Heart Rhythm|February 2, 2012
Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndromeJason Costa, Coeli M Lopes, Alon Barsheshet, et al.
JACC. Cardiovascular Interventions|July 24, 2024
3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid StudyFiras Zahr, Basel Ramlawi, Michael J Reardon, et al.
Journal of the American College of Cardiology|November 24, 2018
Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart FailureDaniel B Mark, Patricia A Cowper, Kevin J Anstrom, et al.
The New England Journal of Medicine|January 7, 2011
AIP mutation in pituitary adenomas in the 18th century and todayHarvinder S Chahal, Karen Stals, Martina Unterländer, et al.
Journal of the American College of Cardiology|August 31, 2019
Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection FractionJames L Januzzi, Tariq Ahmad, Hillary Mulder, et al.
JACC. Heart Failure|December 3, 2014
Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trialW H Wilson Tang, Matthias Dupont, Adrian F Hernandez, et al.
Canadian Family Physician Medecin De Famille Canadien|October 13, 2023
Lipid-lowering therapies for cardiovascular disease prevention and management in primary care: PEER umbrella systematic review of systematic reviewsNicolas Dugré, Adrienne J Lindblad, Danielle Perry, et al.
Circulation|June 29, 2026
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)Mary Norine Walsh, Lars Kober, Karen Sliwa, et al.
JACC. Heart Failure|April 13, 2020
Endpoints in Heart Failure Drug Development: History and FutureMona Fiuzat, Naomi Lowy, Norman Stockbridge, et al.
European Heart Journal|March 24, 2022
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trialScott D Solomon, Brian L Claggett, Zi Michael Miao, et al.
Pageof 131